Shifting preference towards minimal invasive surgical procedures, strong prevalence of cardiovascular diseases, increasing number of patients affected with lifestyle disorders, and technological advancement in medical technology are the major factors driving the growth of the global coronary guidewire market. The coronary guidewires are used to establish a route towards the lesion or blockage in the coronary system and navigate the surgical instruments for surgical procedures. The coronary guidewires are primarily used during the percutaneous transluminal angioplasty (PTA) and percutaneous transluminal coronary angioplasty (PTCA) for placement of balloon dilatation catheters.
The prevalence of cardiovascular diseases has increased significantly during past few decades fueled by expanding obese population and emergence of other lifestyle disorders. Additionally, with expanding geriatric population, the burden of cardiovascular diseases is anticipated to increasing in coming years. However, advancements in medical technology has significantly helped to tackle the health hazards posed by cardiovascular diseases. Emergence and adoption of minimal invasive surgical procedures for treatment of intricate medical conditions such as atherosclerosis has fueled the adoption of advanced surgical equipment such as coronary stents, coronary guidewires, catheters, and other devices. This has fueled the growth of the global coronary guidewire market. The global coronary guidewire market is expected to grow significantly during the forecast period.
North America contributed the largest share to the global coronary guidewires market owing to strong prevalence of cardiovascular diseases, increasing investment in new product development, and rising awareness regarding cardiovascular disorders. Additionally, presence of leading medical device manufacturing companies and availability of robust healthcare infrastructure is anticipated to contribute towards the growth of North America coronary guidewire market in coming years.
Asia Pacific contributed a prominent share to the global coronary guidewire market in 2019 and is expected to be the fastest growing segment during the forecast period. Increasing number of cardiovascular patients, rising awareness, increasing adoption of advanced medical technology and expansion of healthcare equipment manufacturing industry are anticipated to bolster the growth of Asia Pacific coronary guidewire market during the forecast period.
The report titled “Coronary Guidewires Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032”, wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global coronary guidewires market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Abbott Laboratories reported revenues of US$ 31.9 billion in 2019 and the product segment analysis of the company indicates that Medical Devices business segment of the company dominated revenue in 2019.
The global coronary guidewires market is segmented based on material, tip flexibility, coating type, end user, and geography. Based on material, the global coronary guidewires market is segmented into nitinol, stainless steel, and hybrid. Based on tip flexibility, the global coronary guidewires market is segmented into soft, intermediate, and hard. Based on coating type, the global coronary guidewires market is segmented into hydrophobic coating and hydrophilic coating. Based on end user, the global coronary guidewires market is segmented into hospitals, specialty clinics, and others. Based on geography, the global Coronary Guidewires market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on coronary guidewires. Further, market share of prominent companies in the global coronary guidewires market would also be estimated. For instance, Abbott Laboratories operates through four business segments namely Established Pharmaceutical Products, Nutritionals, Diagnostics, and Medical Devices. The coronary guidewires are delivered under Medical Devices business segment of the company with revenue contribution of US$ 12,239 million in 2019.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the coronary guidewires companies. The global coronary guidewires market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the coronary guidewires business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global coronary guidewires market.
Major players active in the global coronary guidewires market include Abbott Laboratories, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cardinal Health, Inc, Integer Holdings Corporation, JOTEC GmbH, Medtronic PLC, Merit Medical Systems, QXMedical, LLC, and Terumo Medical Corporation.
The Global Coronary Guidewires Market Is Segmented As Below:
Based On Material
Based On Tip Flexibility
Based On Coating Type
Based On End User
By Regions
The coronary guidewires analysis market has been assessed for the years 2019 to 2032.
Shifting preference towards minimal invasive surgical procedures, strong prevalence of cardiovascular diseases, increasing number of patients affected with lifestyle disorders, and technological advancement in medical technology are the major factors driving the growth of the global coronary guidewire market.
North America contributed the largest share to the global coronary guidewires market owing to strong prevalence of cardiovascular diseases, increasing investment in new product development, and rising awareness regarding cardiovascular disorders.
Key coronary guidewires market players are Abbott Laboratories, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cardinal Health, Inc, Integer Holdings Corporation, JOTEC GmbH, Medtronic PLC, Merit Medical Systems, QXMedical, LLC, and Terumo Medical Corporation.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved